Press Releases

Phastar announced the acquisition of S-Cubed ApS, a specialist biometrics and data visualization company. The deal takes the PHASTAR group to around 550 people worldwide and strengthens the company's position in the Nordic region. Andrew MacGarvey, CEO of Phastar, commented,...

AbbVie and Immunome, Inc., a clinical-stage biopharmaceutical company that utilizes its human memory B cell platform to discover and develop first-in-class antibody therapeutics, announced a worldwide collaboration and option agreement directed to the discovery of up to 10 novel...

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and CytomX Therapeutics, Inc., a leader in the field of conditionally activated oncology therapeutics, announced a collaboration and licensing agreement to create investigational mRNA-based conditionally activated therapies...

WuXi Biologics , a leading global Contract Research, Development, and Manufacturing Organization announced a license agreement with GSK plc under which GSK will have exclusive licenses for up to four bi- & multi-specific TCE antibodies developed using WuXi Biologics' proprietary...

TMC Pharma Services, an international Pharmaceutical Development Organisation specialising in Orphan Drug development, has appointed Gordon Cameron as a Non-Executive Director to support the growth of the business. Gordon brings 25 years’ board-level experience in in the biotech and pharmaceutical...

Hetero, India’s leading pharmaceutical company with the widest global reach, announced the receipt of World Health Organization Prequalification of Medicines Program (WHO PQ) approval for its generic version of COVID-19 oral antiviral treatment candidate nirmatrelvir. This is the first...

WuXi STA, a subsidiary of WuXi AppTec, announced that its first drug product Continuous Manufacturing (CM) line for oral solids is in operation at the drug product site located in Wuxi city, China. This new CM line provides global...